Prelude Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.57M Buy
153,545
+109,465
+248% +$1.83M 0.25% 91
2025
Q1
$678K Buy
44,080
+23,400
+113% +$360K 0.05% 358
2024
Q4
$456K Buy
20,680
+4,055
+24% +$89.4K 0.03% 532
2024
Q3
$300K Buy
16,625
+203
+1% +$3.66K 0.02% 779
2024
Q2
$267K Buy
16,422
+94
+0.6% +$1.53K 0.02% 755
2024
Q1
$230K Buy
+16,328
New +$230K 0.01% 933
2021
Q3
Hold
0
1700
2021
Q2
Hold
0
1625
2020
Q4
Sell
-1,844
Closed -$17K 1512
2020
Q3
$17K Buy
+1,844
New +$17K ﹤0.01% 1027
2020
Q2
Hold
0
1688
2020
Q1
Sell
-12,912
Closed -$127K 1530
2019
Q4
$127K Buy
+12,912
New +$127K ﹤0.01% 661
2019
Q3
Sell
-364
Closed -$3K 1560
2019
Q2
$3K Sell
364
-16,486
-98% -$136K ﹤0.01% 1153
2019
Q1
$264K Buy
16,850
+3,249
+24% +$50.9K 0.01% 382
2018
Q4
$210K Buy
13,601
+2,504
+23% +$38.7K 0.01% 487
2018
Q3
$239K Buy
11,097
+9,603
+643% +$207K 0.01% 490
2018
Q2
$36K Buy
+1,494
New +$36K ﹤0.01% 961
2018
Q1
Sell
-36,188
Closed -$686K 1556
2017
Q4
$686K Buy
36,188
+18,529
+105% +$351K 0.06% 293
2017
Q3
$311K Buy
+17,659
New +$311K 0.03% 456
2017
Q1
Sell
-18,500
Closed -$671K 1708
2016
Q4
$671K Buy
+18,500
New +$671K 0.08% 247
2016
Q3
Sell
-10,069
Closed -$506K 1740
2016
Q2
$506K Buy
10,069
+1,200
+14% +$60.3K 0.07% 256
2016
Q1
$475K Hold
8,869
0.07% 277
2015
Q4
$582K Sell
8,869
-1,155
-12% -$75.8K 0.09% 215
2015
Q3
$566K Buy
+10,024
New +$566K 0.08% 227
2015
Q1
Sell
-1,420
Closed -$82K 2064
2014
Q4
$82K Sell
1,420
-60
-4% -$3.47K 0.01% 1008
2014
Q3
$80K Sell
1,480
-100
-6% -$5.41K 0.01% 1099
2014
Q2
$83K Buy
+1,580
New +$83K 0.01% 1048